𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Use of Galiximab in Non-Hodgkin Lymphoma

✍ Scribed by Vinjamaram, Sanjay; Czuczman, Myron S.; Hernandez-Ilizaliturri, Francisco J.

Book ID
119936041
Publisher
CIG Media Group, LP.
Year
2008
Tongue
English
Weight
230 KB
Volume
8
Category
Article
ISSN
1557-9190

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Use of cytosar in pediatric non-Hodgkin
Use of cytosar in pediatric non-Hodgkin lymphoma
✍ Sullivan, M. P. ;Ramirez, I. ;Pullen, J. ;Moore, T. ;Doering, E. J. ;Falletta, J πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 320 KB

Cytosar, as a component of LSAz-Lz therapy, was given in combination with thioguanine in consolidation by schedules used in acute granulocytic leukemia. Daily Cytosar injections were given for 4 days in maintenance. In an effort to increase efficacy, second generation LSAz-Lz therapy employs Cytosar

Non-Hodgkin lymphoma
Non-Hodgkin lymphoma
✍ Linda S Evans; Barry W Hancock πŸ“‚ Article πŸ“… 2003 πŸ› The Lancet 🌐 English βš– 121 KB
Non-Hodgkin lymphoma
Non-Hodgkin lymphoma
✍ Kate R Shankland; James O Armitage; Barry W Hancock πŸ“‚ Article πŸ“… 2012 πŸ› The Lancet 🌐 English βš– 185 KB